![Peter A. Harris](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Peter A.
Harris was appointed Chief Medical Officer for Oxigene, Inc. in June 2006.
He is a Fellow of the Royal Society of Medicine.
He is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians and a Senior Specialty Advisor.
Dr. Harris held various positions at Roche Products Ltd.
from 1978 to 1985, including the Head of Drug Safety and the Head of Medical Affairs.
From July 2001 to May 2006, he was a Development Director for KuDOS Pharmaceuticals.
He was Director of Clinical Research Europe for Amgen Ltd.
from 1992 to 1994.
Dr. Harris was the Head of Medical Affairs for ICI Pharmaceuticals from 1987 to 1992.
He was Medical Director for Revlon Healthcare from 1985 to 1987 and Medical Director for COBRA Therapeutics from 1994 to 2001.
He received a BS degree from the University of London, a Bachelor of Medicine/Bachelor of Surgery degree from The Royal London Hospital Medical School at the University of London and a Diploma in Pharmaceutical Medicine from the Royal College of Physicians.
Eerdere bekende functies van Peter A. Harris
Bedrijven | Functie | Einde |
---|---|---|
ONCOTELIC THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 31-08-2007 |
Opleiding van Peter A. Harris
University of London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ONCOTELIC THERAPEUTICS, INC. | Health Technology |